SF3B1 and B-cell chronic lymphocytic leukemia: In CLL cells, sudemycin D1 and D6 were also more cytotoxic for cells bearing SF3B1 mutations or other RNA splicing–related genes, both in vitro and in vivo (Xargay-Torrent et al, 2015), but these drugs have not entered into clinical trials.